Bydureon is an injectable drug containing Exenatide that is used to improve glycemic control in adults with (non-insulin dependent) type 2 diabetes mellitus.
Clinical and pharmacological group: Selective estrogen receptor modulator for the prevention of postmenopausal osteoporosis
Pharmacotherapeutic group: Bone resorption inhibitor